Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Disposition to Issuer of 1,700 BRNS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Barinthus Biotherapeutics plc. (BRNS) | Disposition to Issuer | 1,700 | n/a |
| May 18, 2026 | REPLIGEN CORP (RGEN) | Grant/Award | 995 | n/a |
| Dec 18, 2025 | REPLIGEN CORP (RGEN) | Sale | 275 | $44.3K |
| Jun 11, 2025 | Barinthus Biotherapeutics plc. (BRNS) | Grant/Award | 20,174 | n/a |
| May 19, 2025 | REPLIGEN CORP (RGEN) | Grant/Award | 973 | n/a |
| Jun 14, 2024 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 2,953 | $199.9K |
| May 20, 2024 | REPLIGEN CORP (RGEN) | Grant/Award | 803 | n/a |
| May 14, 2024 | Barinthus Biotherapeutics plc. (BRNS) | Grant/Award | 19,516 | n/a |
| Feb 29, 2024 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 4,626 | $194.6K |
| Aug 30, 2023 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 7,392 | $133.9K |